SUBSCRIBE
SUBSCRIBE

Tvardi Therapeutics

IN THE PRESS
Press Releases
Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 9, 2026
 · 
4 min read
Press Releases
Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights
January 8, 2026
 · 
6 min read
Press Releases
Tvardi Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 19, 2025
 · 
1 min read
Press Releases
Tvardi Therapeutics Announces Third Quarter 2025 Results and Provides Business Update
November 14, 2025
 · 
9 min read
Press Releases
Tvardi Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference in London
November 5, 2025
 · 
1 min read
Press Releases
Tvardi Therapeutics Provides Update on Preliminary Data from Phase 2 REVERT Trial in Idiopathic Pulmonary Fibrosis
October 14, 2025
 · 
7 min read
Press Releases
Tvardi Therapeutics to Participate in the Cantor Global Healthcare Conference
August 21, 2025
 · 
1 min read
Press Releases
Tvardi Therapeutics Announces Second Quarter 2025 Results and Provides Business Update
August 15, 2025
 · 
8 min read
Press Releases
Tvardi Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
July 15, 2025
 · 
1 min read
Press Releases
Tvardi Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of TTI-101 in Idiopathic Pulmonary Fibrosis
May 27, 2025
 · 
5 min read
Load More
JOBS